Tavares TP, Mitchell DGV, Coleman KK, et al. Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration. J Neurol Neurosurg & Psychiatry 2020;91:975–84. doi: 10.1136/jnnp-2020-322987.

The Genetic FTD Initiative, (GENFI) should have been listed in the paper.

List of GENFI Consortium Members

• Alazne Gabilondo - Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain

• Albert Lladó - Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain

• Alessandro Padovani - Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

• Ana Gorostidi - Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain

• Ana Verdelho - Department of Neurosciences and Mental Health, Centro Hospitalar Lisboa Norte - Hospital de Santa Maria & Faculty of Medicine, University of Lisbon, Lisbon, Portugal

• Andrea Arighi - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy; University of Milan, Centro Dino Ferrari, Milan, Italy

• Anna Antonell - Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain

• Beatriz Santiago - Neurology Department, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal

• Begoña Indakoetxea - Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain

• Benedetta Nacmias - Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy

• Benjamin Bender - Department of Diagnostic and Interventional Neuroradiology, University of Tübingen, Tübingen, Germany

• Camilla Ferrari - Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy

• Carlo Wilke - Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany

• Carolin Heller - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Carolina Maruta - Laboratory of Language Research, Centro de Estudos Egas Moniz, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

• Caroline Greaves - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Carolyn Timberlake - Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK

• Catarina B. Ferreira - Laboratory of Neurosciences, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

• Catharina Prix - Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany

• Chiara Fenoglio - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy; University of Milan, Centro Dino Ferrari, Milan, Italy

• Christin Andersson - Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

• Cristina Polito - Department of Biomedical, Experimental and Clinical Sciences “Mario Serio”, Nuclear Medicine Unit, University of Florence, Florence, Italy

• David Cash - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• David L Thomas - Neuroimaging Analysis Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Queen Square, London, UK

• David Tang-Wai - The University Health Network, Krembil Research Institute, Toronto, Canada

• Diana Duro - Faculty of Medicine, University of Coimbra, Coimbra, Portugal

• Ekaterina Rogaeva - Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada

• Elio Scarpini - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy; University of Milan, Centro Dino Ferrari, Milan, Italy

• Elisa Semler - Department of Neurology, University of Ulm, Ulm

• Elisabeth Wlasich - Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany

• Emily Todd - Department of Neurodegenerative Disease, UCL Institute of Neurology, UK

• Enrico Premi - Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

• Gabriel Miltenberger - Faculty of Medicine, University of Lisbon, Lisbon, Portugal

• Gemma Lombardi - Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy

• Georgia Peakman - Department of Neurodegenerative Disease, UCL Institute of Neurology, UK

• Giacomina Rossi - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

• Giorgio Fumagalli - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy; University of Milan, Centro Dino Ferrari, Milan, Italy; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy

• Giorgio Giaccone - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

• Giuliano Binetti - Istituto di Ricovero e Cura a Carattere Scientifico Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

• Giuseppe Di Fede - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

• Hakan Thonberg - Centre for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden

• Hans-Otto Karnath - Division of Neuropsychology, Hertie-Institute for Clinical Brain Research and Centre of Neurology, University of Tübingen, Tübingen, Germany

• Henrik Zetterberg - Dementia Research Institute, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Ione Woollacott - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Janne Papma - Department of Neurology, Erasmus Medical Centre, Rotterdam

• Jason Warren - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Jaume Olives - Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain

• Jennifer Nicholas - Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK

• Jessica Panman - Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands

• Jorge Villanua - OSATEK, University of Donostia, San Sebastian, Gipuzkoa, Spain

• Jose Bras - Dementia Research Institute, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Katrina Moore - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London UK

• Lieke Meeter - Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands

• Linn Öijerstedt - Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden

• Lize Jiskoot - Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands

• Luisa Benussi - Istituto di Ricovero e Cura a Carattere Scientifico Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

• María de Arriba - Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain

• Maria João Leitão - Centre of Neurosciences and Cell Biology, Universidade de Coimbra, Coimbra, Portugal

• Maria Rosario Almeida - Faculty of Medicine, University of Coimbra, Coimbra, Portugal

• Martin Rosser - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Martina Bocchetta - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Mathieu Vandenbulcke - Geriatric Psychiatry Service, University Hospitals Leuven, Belgium; Neuropsychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium

• Maura Cosseddu - Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

• Michela Pievani - Istituto di Ricovero e Cura a Carattere Scientifico Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

• Michele Veldsman - Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK

• Miguel Castelo-Branco - Faculty of Medicine, University of Coimbra, Coimbra, Portugal

• Miguel Tábuas-Pereira - Neurology Department, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal

• Mikel Tainta - Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain

• Mircea Balasa - Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain

• Miren Zulaica - Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain

• Morris Freedman - Baycrest Health Sciences, Rotman Research Institute, University of Toronto, Toronto, Canada

• Myriam Barandiaran - Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain

• Nick Fox - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Nuria Bargalló - Imaging Diagnostic Centre, Hospital Clínic, Barcelona, Spain

• Paola Caroppo - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

• Pedro Rosa-Neto - Translational Neuroimaging Laboratory, McGill Centre for Studies in Ageing, McGill University, Montreal, Québec, Canada

• Philip Vandamme - Neurology Service, University Hospitals Leuven, Belgium; Laboratory for Neurobiology, VIB-KU Leuven Centre for Brain Research, Leuven, Belgium

• Pietro Tiraboschi - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

• Rachelle Shafei - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Rhian Convery - Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Ricardo Taipa - Neuropathology Unit and Department of Neurology, Centro Hospitalar do Porto - Hospital de Santo António, Oporto, Portugal

• Rick van Minkelen - Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, Netherlands

• Rita Guerreiro - Dementia Research Institute, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Robart Bartha - Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada; Centre for Functional and Metabolic Mapping, Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada

• Roberto Gasparotti - Neuroradiology Unit, University of Brescia, Brescia, Italy

• Ron Keren - The University Health Network, Toronto Rehabilitation Institute, Toronto, Canada

• Rosa Rademakers - Department of Neurosciences, Mayo Clinic, Jacksonville, Florida, USA

• Rose Bruffaerts - Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium

• Sandra Black - Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada

• Sandra Loosli - Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany

• Sara Mitchell - Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada

• Sara Prioni - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

• Sarah Anderl-Straub - Department of Neurology, University of Ulm, Ulm, Germany

• Sebastien Ourselin - School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK

• Serge Gauthier - Alzheimer Disease Research Unit, McGill Centre for Studies in Ageing, Department of Neurology & Neurosurgery, McGill University, Montreal, Québec, Canada

• Sergi Borrego-Ecija - Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain

• Silvana Archetti - Biotechnology Laboratory, Department of Diagnostics, Spedali Civili Hospital, Brescia, Italy

• Simon Mead - MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK

• Sónia Afonso - Instituto Ciencias Nucleares Aplicadas a Saude, Universidade de Coimbra, Coimbra, Portugal

• Sonja Schönecker - Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany

• Stefano Gazzina - Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

• Thomas Cope - Department of Clinical Neuriscience, University of Cambridge, Cambridge, UK

• Tim Rittman - Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK

• Tobias Hoegen - Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany

• Toby Flanagan - Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK

• Valentina Bessi - Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy

• Veronica Redaelli - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy

• Vesna Jelic - Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden

• Yolande Pijnenburg - Amsterdam University Medical Centre, Amsterdam VUmc, Amsterdam, Netherlands

• Zigor Díaz - CITA Alzheimer, San Sebastian, Gipuzkoa, Spain